UnitedHealth Group (UNH)
(Delayed Data from NYSE)
$579.67 USD
+5.43 (0.95%)
Updated Aug 14, 2024 04:00 PM ET
After-Market: $579.01 -0.66 (-0.11%) 6:00 PM ET
3-Hold of 5 3
B Value D Growth C Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$579.67 USD
+5.43 (0.95%)
Updated Aug 14, 2024 04:00 PM ET
After-Market: $579.01 -0.66 (-0.11%) 6:00 PM ET
3-Hold of 5 3
B Value D Growth C Momentum C VGM
Zacks News
UnitedHealth Group, Inc. is the largest health care services company in the world, serving over 50 million individuals in the United States as of 2019 and over 5 million internationally. The company provides a wide range of health care products and services, such as health maintenance organizations (HMOs), point of service plans (POS), preferred provider organizations (PPOs), and managed fee-for-service programs. UnitedHealth has the largest and most diverse membership base within the managed-care organization market, which gives it significant competitive advantages. It also has built its prescription drug business through OptumRx division, with the acquisition of Catamaran in 2015.
Anthem Ties Up With Walmart to Better Serve Medicare Members
by Zacks Equity Research
Anthem (ANTM) teams up with Walmart to provide medical supplies across its counter.
Top Ranked Growth Stocks to Buy for August 21st
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, August 21st:
Aetna (AET) Reaches 52-Week High on a Solid Second Quarter
by Zacks Equity Research
Aetna's (AET) shares scale a 52-week high on Aug 17, 2018 led by strong second-quarter performance.
Dow Reaches Its Highest Level Since February: 4 Top Picks
by Nalak Das
Recent optimism related to global trade war concerns, a robust U.S. economy and strong earnings results are likely to pave the way for further upside of the Dow 30.
Top Ranked Growth Stocks to Buy for August 20th
by Zacks Equity Research
Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, August 20th:
Why Is UnitedHealth Group (UNH) Up 2.03% Since Its Last Earnings Report?
by Zacks Equity Research
UnitedHealth Group (UNH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
4 Attractive Health Insurers From a Top-Ranked Industry
by Sapna Bagaria
Health insurers are poised for growth on strong demand, new business, use of technology and revenue diversification
UnitedHealth to Spread in Pharmacy Business With Genoa Deal
by Zacks Equity Research
UnitedHealth's (UNH) acquisition of Genoa Health should aid the company's Optum segment.
The Zacks Analyst Blog Highlights: Microsoft, Apple, UnitedHealth and Intel
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Microsoft, Apple, UnitedHealth and Intel
Molina Healthcare Hits 52-Week High: Is Further Upside Left?
by Zacks Equity Research
Molina Healthcare (MOH) stock gains as its restructuring initiatives start bearing fruit.
Buy 4 Terrific Dow Stocks on the Dip
by Nalak Das
Recent stock market meltdown is a temporary phenomenon as U.S. companies do not have significant exposure in Turkey.
Top Research Reports: UnitedHealth, PepsiCo, Amgen & More
by Kalyan Nandy
Today's Research Daily features updated research reports on 12 major stocks, including UnitedHealth (UNH), PepsiCo (PEP) and Amgen (AMGN).
Humana Completes Sale of KMG Subsidiary to HC2 Holdings
by Zacks Equity Research
Humana (HUM) divests its long-term care business to focus on core operations.
Top Ranked Growth Stocks to Buy for August 10th
by Zacks Equity Research
Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, August 10th:
WellCare Health Sees Moody's Rating Action, Outlook Stable
by Zacks Equity Research
WellCare Health (WCG) and unit get Moody's ratings while the outlook changes to stable.
Top Ranked Growth Stocks to Buy for August 8th
by Zacks Equity Research
Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, August 8th:
Tenet Healthcare (THC) Q2 Earnings Top & Up Y/Y, Revenues Lag
by Zacks Equity Research
Tenet Healthcare's (THC) second-quarter earnings impress with solid performances at the Ambulatory Segment.
Envision Healthcare (EVHC) Q2 Earnings Beat, Revenues Miss
by Zacks Equity Research
Envision Healthcare (EVHC) Q2 earnings were backed by higher contribution from its segments.
Top Ranked Growth Stocks to Buy for August 6th
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, August 6th:
Aetna (AET) Q2 Earnings Beat Estimates, Membership Declines
by Zacks Equity Research
Aetna's (AET) Q2 earnings gained from a lower tax rate partly offset by increase in expenses.
Cigna (CI) Q2 Earnings & Revenues Beat, 2018 View Raised
by Zacks Equity Research
Cigna's (CI) Q2 earnings gain on premium and customer growth.
Teladoc (TDOC) Incurs Narrower-Than-Expected Loss in Q2
by Zacks Equity Research
Teladoc (TDOC) incurs loss owing to high expenses, partly offset by revenue growth.
Top Ranked Growth Stocks to Buy for August 2nd
by Zacks Equity Research
Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, August 2nd:
Humana (HUM) Surpasses on Q2 Earnings, Raises EPS Guidance
by Zacks Equity Research
Humana's (HUM) Q2 earnings register growth on the back of Medicare Advantage enrollment and solid strategies. The company also lifts its EPS outlook.
Molina Healthcare (MOH) Tops Q2 Earnings, Updates '18 View
by Zacks Equity Research
Molina Healthcare's (MOH) Q2 gains from a decline in expense. The company also revises its full-year guidance.